Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis

被引:24
作者
Georges, C
Chassany, O
Mouthon, L
Tiev, K
Marjanovic, Z
Meyer, O
Toledano, C
Ilie, D
Guillevin, L
Sereni, D
Cabane, J
Farge, D
机构
[1] Hop St Louis, Serv Med Interne, F-75475 Paris 10, France
[2] Hop St Louis, Delegat Rech Clin, F-75475 Paris 10, France
[3] Hop Avicenne, F-93000 Bobigny, France
[4] Hop St Antoine, F-75012 Paris, France
[5] Hop Bichat Claude Bernard, F-75018 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2004年 / 25卷 / 01期
关键词
scleroderma; systemic sclerosis; SF-36; quality of life;
D O I
10.1016/S0248-8663(03)00268-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective- To investigate the metric properties and the validity of the Medical Outcome Study Short Form 36 (SF-36), a questionnaire to assess the quality of life, in patients with either diffuse or limited systemic sclerosis (SS), and to examine the effect of the disease on quality of life. Methods- Cross sectional study of 86 patients with a SS (64 diffuse SS, 22 limited SS). Disease severity was assessed by clinical examination, pulmonary functional tests and Health Assessment Questionnaire (HAQ) modified for scleroderma. Results- The SF-36 scores values were lower in diffuse than in limited sclerodermie systemique. The Physical Component Score was worse in patients with than without any clinical involvement. This score increased in relation with the number of clinical involvements. The quality of life of patients with SS was correlated to its functional repercussion. Conclusion- The quality of life in SS patients is correlated with the clinical severity of the disease. The use of SF-36 to measure the quality of life is useful for the clinical evaluation of patients with SS. (C) 2003 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 16 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]   Validation of a specific quality of life questionnaire for functional digestive disorders [J].
Chassany, O ;
Marquis, P ;
Scherrer, B ;
Read, NW ;
Finger, T ;
Bergmann, JF ;
Fraitag, B ;
Geneve, J ;
Caulin, C .
GUT, 1999, 44 (04) :527-533
[3]  
CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
[4]   Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study [J].
Farge, D ;
Marolleau, JP ;
Zohar, S ;
Marjanovic, Z ;
Cabane, J ;
Mounier, N ;
Hachulla, E ;
Philippe, P ;
Sibilia, J ;
Rabian, C ;
Chevret, S ;
Gluckman, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) :726-739
[5]  
FRIES JF, 1982, J RHEUMATOL, V9, P789
[6]   Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables [J].
Juenger, J ;
Schellberg, D ;
Kraemer, S ;
Haunstetter, A ;
Zugck, C ;
Herzog, W ;
Haass, M .
HEART, 2002, 87 (03) :235-241
[7]   The French SF-36 Health Survey:: Translation, cultural adaptation and preliminary psychometric evaluation [J].
Leplège, A ;
Ecosse, E ;
Verdier, A ;
Perneger, TV .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1013-1023
[8]  
LeRoy EC, 2001, J RHEUMATOL, V28, P1573
[9]   EVALUATION OF THE SHORT-FORM 36-ITEM QUESTIONNAIRE TO MEASURE HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH COPD [J].
MAHLER, DA ;
MACKOWIAK, JI .
CHEST, 1995, 107 (06) :1585-1589
[10]  
Medsger TA, 1999, J RHEUMATOL, V26, P2159